Post Reply
1561-1580 of 1587
Wow u big leg. I still waiting 140. But look like no chance
Sgvale ( Date: 03-Feb-2020 10:31) Posted:
| I got 141 again small small. Total 100 lots now |
|
I got 141 again small small. Total 100 lots now
Yeah. Someone married deal at 148 700lot
trademaster ( Date: 03-Feb-2020 10:28) Posted:
Wow u are here too...this is one of my fav darlings...140-145 all can grab. TP 160 at least near term
guards80 ( Date: 03-Feb-2020 10:17) Posted:
| Yes lowest 132. But i think wont go back liaoz. Im queue buy 140 again. 🍍 |
|
|
|
Wow u are here too...this is one of my fav darlings...140-145 all can grab. TP 160 at least near term
guards80 ( Date: 03-Feb-2020 10:17) Posted:
Yes lowest 132. But i think wont go back liaoz. Im queue buy 140 again. 🍍
gravity8888 ( Date: 03-Feb-2020 10:04) Posted:
| Guard.. Nice... Think the support is 132. |
|
|
|
Yes lowest 132. But i think wont go back liaoz. Im queue buy 140 again. 🍍
gravity8888 ( Date: 03-Feb-2020 10:04) Posted:
| Guard.. Nice... Think the support is 132. |
|
Guard.. Nice... Think the support is 132.
Good can collect more again 👍 lowest is 132
Think 145 break will be push up liaoz
Go back 60cent? Hehe
newpattern ( Date: 03-Feb-2020 09:15) Posted:
The bridge is clearer now !!!!
guards80 ( Date: 03-Feb-2020 09:14) Posted:
| Queue another 100lot at 140 collecting more before push up above 16 |
|
|
|
The bridge is clearer now !!!!
guards80 ( Date: 03-Feb-2020 09:14) Posted:
Queue another 100lot at 140 collecting more before push up above 160
guards80 ( Date: 03-Feb-2020 09:13) Posted:
|
|
|
Queue another 100lot at 140 collecting more before push up above 160
guards80 ( Date: 03-Feb-2020 09:13) Posted:
Huat ah
Sgvale ( Date: 03-Feb-2020 09:11) Posted:
|
|
|
Huat ah
Sgvale ( Date: 03-Feb-2020 09:11) Posted:
I got 80 at 142-143
guards80 ( Date: 03-Feb-2020 09:06) Posted:
| I buy 100lot at 142 huat a |
|
|
|
I got 80 at 142-143
guards80 ( Date: 03-Feb-2020 09:06) Posted:
I buy 100lot at 142 huat ah
guards80 ( Date: 03-Feb-2020 09:04) Posted:
| Is 148 700lot married dea |
|
|
|
I buy 100lot at 142 huat ah
guards80 ( Date: 03-Feb-2020 09:04) Posted:
Is 148 700lot married deal
guards80 ( Date: 03-Feb-2020 09:03) Posted:
| 142. Someone buy at 147 700lot |
|
|
|
Is 148 700lot married deal
guards80 ( Date: 03-Feb-2020 09:03) Posted:
| 142. Someone buy at 147 700lot |
|
142. Someone buy at 147 700lot
Guards you buying what price?
Clearbridge Health: Fair Value S$0.410 - - Tayrona Financial
High Growth Markets to Bring Tremendous Upside 
▪ Medical treatment will become more personalised. Clearbridge Health Limited is focused on the delivery of precision medicine through its offices and healthcare facilities in the region. We see high growth potential for the Company as doctors increasingly customize treatments to patients&rsquo genetic composition. Emerging areas of precision medicine include diagnostics, e.g. direct-to-consumer DNA tests, drug sensitivity testing and cancer treatment (precision oncology). With its network across Asia, Clearbridge is positioning itself to tap on this trend over the next five to ten years.
▪ Portfolio of prized assets in Southeast Asia&rsquo s fastest growing markets. Via acquisitions over the last two years, Clearbridge has established credible footholds in the Philippines and Indonesia. For instance, Clearbridge owns the largest chain of clinical laboratories and renal dialysis centres co-located in some of the best hospitals in Indonesia. Hence, Clearbridge will also benefit from growing demand for healthcare in these markets. In Singapore, it has acquired a medical-cum-aesthetic clinic and a chain of dental clinics, thus giving it access to professional expertise that it can export and replicate in Philippines and Indonesia.
▪ Associate Biolidics is making waves in China. Clearbridge&rsquo s 24.8% owned Biolidics Limited has been working with partners to develop clinical and laboratory tests using its patented technology to separate tumour cells from blood. Liquid biopsies can be used to detect cancer early and monitor disease and has been touted as a game changer in cancer treatment. In the US, similar companies have captured the attention of pharma giants and have been the subject of several acquisitions over the last two years.
▪ Key risks. We noted that Clearbridge does not have a track record of positive profitability. These losses have been partly due to investments made in prior years. With a stream of profitable acquisitions, we expect Clearbridge to turn EBITDA positive in 2020 and report its maiden profit in 2021. One key merit is that the Company&rsquo s management has a track record of running and monetizing medical technology businesses.
▪ Potential unicorn in the making. Two gene therapies that modify patients&rsquo immune system to fight cancer cells were approved by the FDA in 2017 and 2018, and more treatments are likely to be introduced to the market in the future. In valuing Clearbridge, we refer to precision medicine examples such as Foundation Medicine (acquired by Roche for US$2.4 billion) and Guardant Health (Market cap: US$7.42 billion). Despite being loss making, these companies have successfully attracted attention for their technologies and market presence. 
We believe that Clearbridge deserves an aggressive valuation for its high future growth potential. Hence, we value Clearbridge at US$201.3m or S$0.410 per share with an Overweight rating.
Are u in it?
i think can go 20cents this week